On September 5, 2018 Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, reported that Kevin Hrusovsky, Chief Executive Officer, President and Chairman of Quanterix, will present at the Wells Fargo Securities 2018 Healthcare Conference on Thursday, Sept. 6, 2018 at 9:45 a.m., EDT at The Westin Copley Place in Boston, Mass (Press release, Quanterix, SEPT 5, 2018, View Source [SID1234529299]). Hrusovsky will also be attending Citi’s 13th Annual Biotech Conference on the same day at the Four Seasons Boston, where he is scheduled to meet privately with leading healthcare investors.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!